BMS Launches Pilot Program With WHO In Five African Countries

Bristol-Myers Squibb is scaling up its community-based tuberculosis interventions to support HIV-positive populations in Africa. The U.S. drug maker's charity wing, Bristol-Myers Squibb Foundation signed a collaboration agreement with the World Health Organization and committed $1.2 million to help develop a global guidance involving national TB programs to fight tuberculosis